Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Sheikh, Aziz ^a   Shehata, Yasser A ^a   Brown, Simon G A ^b   Simons, F Estelle R ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; PLACEBO;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE SEVERITY; HUMAN; META ANALYSIS; PATIENT SATISFACTION; QUALITATIVE ANALYSIS; REVIEW; SURVIVAL; SYSTEMATIC REVIEW;

EID: 55049108343     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006312.pub2     Document Type: Review

References (60)

1. Alrasbi 2007 Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 2007;62:838-41.
2. Alves 2001 Alves B, Sheikh A. Age specific aetiology of anaphylaxis. Archives of Disease in Childhood 2001;85:348.
3. Bautista 2002 Bautista E, Simons FER, Simons KJ, Becker AB, Duke K, Tillett M, et al.Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. International Archives of Allergy and Applied Immunology 2002;128:151-64.
4. Begg 1994 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088- 101.
5. Bock 2001 Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. The Journal of Allergy and Clinical Immunology 2001;107:191-3.
6. Bock 2007 Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. The Journal of Allergy and Clinical Immunology 2007;119:1016-8.
7. Bohlke 2004 Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS, Vaccine Safety Datalink Team. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. The Journal of Allergy and Clinical Immunology 2004;113:536-42.
8. Brown 1998 Brown AFT. Therapeutic controversies in the management of acute anaphylaxis. Journal of Accident & Emergency Medicine 1998;15:89-95.
9. Brown 2001 Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. The Journal of Allergy and Clinical Immunology 2001;108:861-6.
10. Brown 2004a Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emergency Medicine Journal 2004;21:149-54.
11. Brown 2004b Brown SG. Clinical features and grading of anaphylaxis. The Journal of Allergy and Clinical Immunology 2004;114:371-6.
12. Brown 2005 Brown SGA. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Current Opinion in Allergy and Clinical Immunology 2005;5:359-64.
13. Brown 2006 Brown SG. Anaphylaxis: clinical concepts and research priorities. Emergency Medicine Australasia 2006;18:155-69.
14. Chamberlain 1999 Chamberlain D. Emergency medical treatment of anaphylactic reactions. Project team of the resuscitation council (UK). Journal of Accident & Emergency Medicine 1999;16:243-7.
15. Clark 2006 Clark S, Gaeta TJ, Kamarthi GS, Camargo CA. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Annals of Epidemiology 2006;16:696-700.
16. Dec Helsinki 1996 World Health Organization. Declaration of Helsinki. BMJ 1996;313:1448-9.
17. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
18. Fischer 1995 Fischer M. Fortnightly review: treatment of acute anaphylaxis. BMJ 1995;311:731-3.
19. Fisher 1978 Fisher MM. Acute life-threatening reactions to contrast media. Aust Radiol 1978;22:365-71.
20. Greenberger 2007 Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: post-mortem findings and associated comorbid diseases. Annals of Allergy, Asthma & Immunology 2007;98:252-7.
21. Hebling 2004 Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clinical and Experimental Allergy 2004;34:285-90.
22. Heilborn 1986 Heilborn H, Hjemdahl P, Daleskog M, Adamsson U. Comparison of subcutaneous injection and high-dose inhalation of epinephrine ? implications for self-treatment to prevent anaphylaxis. Journal of Allergy and Clinical Immunology 1986;76:1174-9.
23. Higgins 2002 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
24. Higgins 2005 Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. http://www.cochrane.org/resources/handbook/hbook.htm.
25. Johansson 2001 Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al.A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-24.
26. Johansson 2004 Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al.Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. The Journal of Allergy and Clinical Immunology 2004;113:832-6.
27. Johnston 2003 Johnston SL, Unsworth J, Gompels M. Adrenaline given outside the context of life threatening allergic reactions. BMJ 2003;326:589-90.
28. Kemp 2002 Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. The Journal of Allergy and Clinical Immunology 2002;110:341-8.
29. Klein 1995 Klein JS, Yocum MW. Underreporting of anaphylaxis in a community emergency room. The Journal of Allergy and Clinical Immunology 1995;95:637-8.
30. Kounis 2006 Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?. International Journal of Cardiology 2006;110:7-14.
31. Lieberman 2003 Lieberman PL. Anaphylaxis and anaphylactoid reactions. Middleton's Allergy: Principles and Practice, 6th edition. Mosby, 2003.
32. Lieberman 2006 Lieberman P, Camargo C, Bohlke K, Jick H, Miller R, Sheikh A, et al.Epidemiology of anaphylaxis: findings of the ACAAI Epidemiology of Anaphylaxis Working Group. Annals of Allergy, Asthma & Immunology 2006;97:596-602.
33. Lin 2000 Lin RY, Schwartz LB, Curry A, Pesola GR, Knight RJ, Lee HS, et al.Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study. The Journal of Allergy and Clinical Immunology 2000;106:65-71.
34. Marone 2004 Marone G, Bova M, Detoraki A, Onorati AM, Rossi FW, Spadaro G. The human heart as a shock organ in anaphylaxis. Novartis Foundation Symposium 2004;257:133-49.
35. McLean-Tooke 2003 McLean-Tooke AP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence?. BMJ 2003;327:1332-5.
36. Mink 2004 Mink SN, Simons FER, Simons KJ, Becker AB, Duke K. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2004;34:1776-83.
37. Montanaro 2002 Montanaro A, Bardana EJ Jr. The mechanisms, causes and treatment of anaphylaxis. Journal of Investigational Allergology & Clinical Immunology 2002;1:2-11.
38. Muller 2007 Muller U. Cardiovascular disease and anaphylaxis. Current Opinion in Allergy and Clinical Immunology 2007;7:337-41.
39. Neugut 2001 Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Archives of Internal Medicine 2001;161:15-21.
40. Peng 2004 Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Archives of Internal Medicine 2004;164:317-9.
41. Pumphrey 2000 Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 2000;30:1144-50.
42. Pumphrey 2007 Pumphrey RSH, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. The Journal of Allergy and Clinical Immunology 2007;119:1018-9.
43. RevMan 5.0 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
44. Sampson 1992 Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. The New England Journal of Medicine 1992;327:380-4.
45. Sampson 2005 Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al.Symposiumon the definition andmanagement of anaphylaxis: summary report. The Journal of Allergy and Clinical Immunology 2005;115:584-91.
46. Sampson 2006 Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al.Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. The Journal of Allergy and Clinical Immunology 2006;117:391-7.
47. Sheikh 2001 Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2001;31:1571-6.
48. Sicherer 2005 Sicherer SH, Simons FER. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. The Journal of Allergy and Clinical Immunology 2005;115:575-83.
49. Simons 1998 Simons FER. Epinephrine absorption in children with a history of anaphylaxis. Journal of Clinical Immunology 1998;101:33-7.
50. Simons 2000 Simons FER, Gu X, Johnston L, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis?. Pediatrics 2000;106:1040-4.
51. Simons 2001 Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. The Journal of Allergy and Clinical Immunology 2001;108:871-3.
52. Simons 2002a Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. The Journal of Allergy and Clinical Immunology 2002;110:647-51.
53. Simons 2002b Simons FER, Chad ZH, Gold M. Real-time reporting of anaphylaxis in infants, children and adolescents by physicians involved in the Canadian Pediatric Surveillance Program. The Journal of Allergy and Clinical Immunology 2002;109 Suppl:181.
54. Simons 2004 Simons FER. First-aid treatment of anaphylaxis to food: Focus on epinephrine. The Journal of Allergy and Clinical Immunology 2004;113:837-44.
55. Simons 2006 Simons FER. Anaphylaxis, killer allergy: Long-term management in the community. The Journal of Allergy and Clinical Immunology 2006;117:367-77.
56. Simons 2007a Simons FER, Frew AJ, Ansotegui IJ, Bochner BS, Finkelman F, Golden DBK, et al.Risk assessment in anaphylaxis: current and future approaches. The Journal of Allergy and Clinical Immunology 2007;120 Suppl:2-24.
57. Simons 2007b Simons FE, Sheikh A. Evidence-based management of anaphylaxis. Allergy 2007;62:827-9.
58. Simons 2008 Simons FER. Emergency treatment of anaphylaxis: Revised UK guidelines are a concise evidence based resource. British Medical Journal 2008;336:1141-2.
59. Soar 2008 Soar J, Pumphrey R, Cant A, et al.for the Working Group of the Resuscitation Council (UK). Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. Resuscitation 2008;77:157-69.
60. Yocum 1999 Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: A population-based study. The Journal of Allergy and Clinical Immunology 1999;104:452-6.